These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23791369)

  • 1. Switching anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Schachat AP
    Am J Ophthalmol; 2013 Jul; 156(1):1-2.e1. PubMed ID: 23791369
    [No Abstract]   [Full Text] [Related]  

  • 2. Current concepts in managing wet AMD suboptimally responsive to anti-VEGF therapy.
    Major JC; Hariprasad SM
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(3):225-6. PubMed ID: 23676221
    [No Abstract]   [Full Text] [Related]  

  • 3. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
    Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB
    Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-VEGF therapy of neovascular age-related macular degeneration: therapeutic strategies status December 2012].
    Pauleikhoff D; Bertram B; Holz FG; Kirchhof B; Bartz-Schmidt U; Bornfeld N; Bresgen M; Eter N; Friedrichs W; Heimann H; Helbig H; Hörauf H; Kampik A; Lemmen KD; Roider J; Ziemssen F
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):170-7. PubMed ID: 23430681
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration.
    Yonekawa Y; Andreoli C; Miller JB; Loewenstein JI; Sobrin L; Eliott D; Vavvas DG; Miller JW; Kim IK
    Am J Ophthalmol; 2013 Jul; 156(1):29-35.e2. PubMed ID: 23668679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial experience with aflibercept in the management of patients with wet age-related macular degeneration refractory to ranibizumab and/or bevacizumab].
    Cervera RE; Castro V; Montero J; Torralba C; Gracia A
    Arch Soc Esp Oftalmol; 2014 Jan; 89(1):42-3. PubMed ID: 24269436
    [No Abstract]   [Full Text] [Related]  

  • 7. Aflibercept anti-vascular endothelial growth factor therapy in vitrectomized eyes with neovascular age-related macular degeneration.
    Jung JJ; Hoang QV; Arain MZ; Chang S
    Acta Ophthalmol; 2016 May; 94(3):e249-50. PubMed ID: 26401896
    [No Abstract]   [Full Text] [Related]  

  • 8. Initial improvements when converting eyes with treatment-resistant exudative AMD to aflibercept are substantially diminished after increasing treatment intervals from 4 to 8 weeks.
    Jørstad ØK; Faber RT; Moe MC
    Acta Ophthalmol; 2015 Sep; 93(6):e510-1. PubMed ID: 25708506
    [No Abstract]   [Full Text] [Related]  

  • 9. Neovascular age-related macular degeneration: individualizing therapy in the era of anti-angiogenic treatments.
    Heier JS
    Ophthalmology; 2013 May; 120(5 Suppl):S23-5. PubMed ID: 23642783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal pigment epithelial tear after intravitreal aflibercept for neovascular age-related macular degeneration.
    Sato T; Ooto S; Suzuki M; Spaide RF
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):87-90. PubMed ID: 25559517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranibizumab therapy for neovascular age-related macular degeneration.
    Folk JC; Stone EM
    N Engl J Med; 2010 Oct; 363(17):1648-55. PubMed ID: 20961248
    [No Abstract]   [Full Text] [Related]  

  • 12. Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration.
    Vaze A; Fraser-Bell S; Gillies M
    Acta Ophthalmol; 2014 Dec; 92(8):e697-8. PubMed ID: 24750589
    [No Abstract]   [Full Text] [Related]  

  • 13. Retina specialists treating age-related macular degeneration recommend different approaches for patients than they would choose for themselves.
    Jeng KW; Wilgucki J; Halperin S; Feuer WJ; Fine HF; Roth D; Prenner JL
    Retina; 2014 Sep; 34(9):1796-801. PubMed ID: 24859475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learnt inform our approach to new antivascular endothelial growth factor treatments for neovascular age-related macular degeneration.
    Wickremasinghe S; Abedi F; Sandhu SS; Guymer R
    Clin Exp Ophthalmol; 2013 Nov; 41(8):723-6. PubMed ID: 24152187
    [No Abstract]   [Full Text] [Related]  

  • 15. Unexpected hypotony after glaucoma drainage implant surgery associated with anti-vascular endothelial growth factor treatment.
    Hoguet A; Parrish RK
    JAMA Ophthalmol; 2015 Mar; 133(3):349-50. PubMed ID: 25474585
    [No Abstract]   [Full Text] [Related]  

  • 16. Neovascular age-related macular degeneration.
    Veritti D; Sarao V; Lanzetta P
    Ophthalmologica; 2012; 227 Suppl 1():11-20. PubMed ID: 22517121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-vascular endothelial growth factors treatment of wet age-related macular degeneration: from neurophysiology to cost-effectiveness.
    Vottonen P
    Acta Ophthalmol; 2018 Feb; 96 Suppl A109():1-46. PubMed ID: 29468838
    [No Abstract]   [Full Text] [Related]  

  • 18. Preferred therapies for neovascular age-related macular degeneration.
    Lally DR; Gerstenblith AT; Regillo CD
    Curr Opin Ophthalmol; 2012 May; 23(3):182-8. PubMed ID: 22450218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti vascular endothelial growth factor sequential therapy for neovascular age-related macular degeneration: is this the new deal?
    Neri P; Mariotti C; Arapi I; Bambini E; Giovannini A
    Curr Med Res Opin; 2012 Mar; 28(3):395-400. PubMed ID: 22283373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repeated intravitreal bevacizumab injections on the inner retinal function in neovascular age-related macular degeneration.
    Kim HD; Kim SH; Cho IH; Moon CH; Ohn YH; Park TK
    Acta Ophthalmol; 2013 Mar; 91(2):e154-6. PubMed ID: 22989051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.